GILD
Gilead Sciences, Inc.
B
69.8 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
13.4%
-
Operating Margin Trend
-1.42 pp/yr
-
5yr Avg ROE
22.5%
-
5yr Share-Count CAGR
-0.1%
-
5yr Revenue CAGR
1.9%
-
5yr EPS CAGR
8.3%
-
Revenue-Growth Years (5)
3/5
-
5yr FCF Margin
33.1%
-
5yr FCF/NI Conversion
5.49x
-
Net Debt / EBITDA
1.03x
-
Interest Coverage (EBIT/Int)
10.57x
-
Altman Z-Score
4.78
Stability
Weight: 15%
C-
50
-
EPS Volatility (σ/μ)
0.72
-
Piotroski F-Score
9
-
Negative-Revenue Years (5)
2/5
4 of 4 gurus held; 1 added; 3 trimmed.
- Holders
- 4
- Avg Δ position
-
-28.5%
- New buys
- 0
- Full exits
- 0